Observational Study to Evaluate the Safety and Efficacy of NovoMix® 70 in Type 2 Diabetes
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
This study is conducted in Europe. The aim of this observational study is to evaluate the
incidence of adverse events while using NovoMix® 70 under normal clinical practice conditions
in Austria.